secwatch / observer
8-K filed July 12, 2022, 7:59 PM ET ticker CVAT CIK 0001376793
leadership confidence high sentiment neutral materiality 0.40

Cavitation Technologies President and Director Igor Gorodnitsky resigns for health reasons

Cavitation Technologies, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Igor Gorodnitsky

Director
CVAT · Cavitation Technologies, Inc.
Effective
2022-07-07
Filed
July 12, 2022, 7:59 PM ET
Additionally, Mr. Gorodnitsky voluntarily resigned from the Company’s Board of Directors, also effective July 7, 2022.
Departed

Igor Gorodnitsky

President
CVAT · Cavitation Technologies, Inc.
Effective
2022-07-07
Filed
July 12, 2022, 7:59 PM ET
On July 5, 2022, Igor Gorodnitsky, the President of Cavitation Technologies, Inc. (the “Company”), voluntarily resigned from such position, effective July 7, 2022, for personal reasons relating to his health.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Igor Gorodnitsky resigned as Director at Cavitation Technologies, Inc..

Action
resigned
Role
Director
Exact text from the filing
Additionally, Mr. Gorodnitsky voluntarily resigned from the Company’s Board of Directors, also effective July 7, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Igor Gorodnitsky resigned as President at Cavitation Technologies, Inc..

Action
resigned
Role
President
Exact text from the filing
On July 5, 2022, Igor Gorodnitsky, the President of Cavitation Technologies, Inc. (the “Company”), voluntarily resigned from such position, effective July 7, 2022, for personal reasons relating to his health.
View on SEC.gov

Cavitation Technologies, Inc. filing history →

Source: SEC EDGAR
accession 0001683168-22-004902
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.